Versant Venture Capital II, LP
CIK 0001354131 Name as filed on the most recent filing
Filed as Versant Venture Capital II, LP (20)
35 transaction lines · from 20 filings · filed 2006-05-15 to 2015-05-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2015-01-05 |
Inogen Inc INGN |
S, Open-market sale | 7,946 disposed | 30.98 | 246,159.13 | Form 4, filing 0001209191-15-002482 | |
| 2014-12-23 |
Inogen Inc INGN |
S, Open-market sale | 9,785 disposed | 29.74 | 291,008.84 | Form 4, filing 0001209191-14-078193 | |
| 2014-11-19 |
Inogen Inc INGN |
S, Open-market sale | 3,500 disposed | 24.22 | 84,756.70 | Form 4, filing 0001209191-14-070176 | |
| 2014-11-18 |
Inogen Inc INGN |
S, Open-market sale | 7,953 disposed | 24.79 | 197,158.05 | Form 4, filing 0001209191-14-070176 | |
| 2014-11-18 |
Inogen Inc INGN |
S, Open-market sale | 3,895 disposed | 24.92 | 97,054.44 | Form 4, filing 0001209191-14-070176 | |
| 2014-11-17 |
Inogen Inc INGN |
S, Open-market sale | 5,343 disposed | 24.89 | 132,961.62 | Form 4, filing 0001209191-14-070178 | |
| 2014-11-17 |
Inogen Inc INGN |
S, Open-market sale | 7,534 disposed | 24.86 | 187,322.36 | Form 4, filing 0001209191-14-070176 | |
| 2014-11-17 |
Inogen Inc INGN |
S, Open-market sale | 5,343 disposed | 24.89 | 132,961.62 | Form 4, filing 0001209191-14-070176 | |
| 2014-11-14 |
Inogen Inc INGN |
S, Open-market sale | 3,928 disposed | 25.06 | 98,446.29 | Form 4, filing 0001209191-14-069010 | |
| 2014-11-14 |
Inogen Inc INGN |
S, Open-market sale | 3,928 disposed | 25.06 | 98,446.29 | Form 4, filing 0001209191-14-069011 | |
| 2014-11-13 |
Inogen Inc INGN |
S, Open-market sale | 5,505 disposed | 25.18 | 138,623.61 | Form 4, filing 0001209191-14-069010 | |
| 2014-11-13 |
Inogen Inc INGN |
S, Open-market sale | 5,505 disposed | 25.18 | 138,640.12 | Form 4, filing 0001209191-14-069011 | |
| 2014-11-10 |
Inogen Inc INGN |
S, Open-market sale | 5,596 disposed | 24.48 | 136,979.45 | Form 4, filing 0001209191-14-067957 | |
| 2014-11-10 |
Inogen Inc INGN |
S, Open-market sale | 3,041 disposed | 24.57 | 74,711.90 | Form 4, filing 0001209191-14-067957 | |
| 2014-11-10 |
Inogen Inc INGN |
S, Open-market sale | 2,992 disposed | 24.42 | 73,064.94 | Form 4, filing 0001209191-14-067956 | |
| 2014-11-07 |
Inogen Inc INGN |
S, Open-market sale | 3,150 disposed | 23.95 | 75,442.18 | Form 4, filing 0001209191-15-040942 | |
| 2014-11-07 |
Inogen Inc INGN |
S, Open-market sale | 3,150 disposed | 23.95 | 75,442.18 | Form 4, filing 0001209191-15-040941 | |
| 2014-11-07 |
Inogen Inc INGN |
S, Open-market sale | 3,150 disposed | 23.95 | 75,442.18 | Form 4, filing 0001209191-14-067470 | |
| 2014-11-07 |
Inogen Inc INGN |
S, Open-market sale | 3,150 disposed | 23.95 | 75,442.18 | Form 4, filing 0001209191-14-067469 | |
| 2014-11-06 |
Inogen Inc INGN |
S, Open-market sale | 4,238 disposed | 24.56 | 104,092.48 | Form 4, filing 0001209191-15-040942 | |
| 2014-11-06 |
Inogen Inc INGN |
S, Open-market sale | 4,238 disposed | 24.56 | 104,092.48 | Form 4, filing 0001209191-15-040941 | |
| 2014-11-06 |
Inogen Inc INGN |
S, Open-market sale | 4,238 disposed | 24.56 | 104,092.48 | Form 4, filing 0001209191-14-067470 | |
| 2014-11-06 |
Inogen Inc INGN |
S, Open-market sale | 4,238 disposed | 24.56 | 104,092.48 | Form 4, filing 0001209191-14-067469 | |
| 2014-10-24 |
Inogen Inc INGN |
S, Open-market sale | 4,647 disposed | 20.76 | 96,455.46 | Form 4, filing 0001209191-14-065135 | |
| 2014-10-09 |
Inogen Inc INGN |
S, Open-market sale | 1,756 disposed | 20.83 | 36,569.58 | Form 4, filing 0001209191-14-063155 | |
| 2014-10-09 |
Inogen Inc INGN |
S, Open-market sale | 144 disposed | 20.83 | 2,998.87 | Form 4, filing 0001209191-14-063155 | |
| 2014-10-08 |
Inogen Inc INGN |
S, Open-market sale | 6,382 disposed | 21.03 | 134,191.76 | Form 4, filing 0001209191-14-062716 | |
| 2014-10-08 |
Inogen Inc INGN |
S, Open-market sale | 525 disposed | 21.03 | 11,038.96 | Form 4, filing 0001209191-14-062716 | |
| 2014-09-09 |
Inogen Inc INGN |
S, Open-market sale | 7,388 disposed | 23.25 | 171,768.04 | Form 4, filing 0001209191-14-057611 | |
| 2009-09-18 |
Helicos Biosciences Corp HLCS |
P, Open-market purchase | 242,931 acquired | 2.57 | 625,012.88 | Form 4, filing 0001209191-09-045187 | |
| 2008-12-23 |
Helicos Biosciences Corp HLCS |
P, Open-market purchase | 8,386,581 acquired | Not reported | Not priced | Form 4, filing 0001209191-08-067548 | |
| 2008-12-23 |
Helicos Biosciences Corp HLCS |
P, Open-market purchase | 159,154 acquired | Not reported | Not priced | Form 4, filing 0001209191-08-067548 | |
| 2008-12-23 |
Helicos Biosciences Corp HLCS |
P, Open-market purchase | 74,955 acquired | Not reported | Not priced | Form 4, filing 0001209191-08-067548 | |
| 2007-05-30 |
Helicos Biosciences Corp HLCS |
P, Open-market purchase | 111,111 acquired | 9.00 | 999,999.00 | Form 4, filing 0001209191-07-034581 | |
| 2006-05-15 |
Novacea Inc NOVC |
P, Open-market purchase | 230,769 acquired | Not reported | Not priced | Form 4, filing 0001181431-06-030242 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Versant Venture Capital II, LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001354131
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6